المؤلفون: Hagström A; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Eugeniavägen 12, 17164, Stockholm, Sweden., Sabazade S; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Eugeniavägen 12, 17164, Stockholm, Sweden.; Ocular Oncology Service, St. Erik Eye Hospital, Stockholm, Sweden., Gill V; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Eugeniavägen 12, 17164, Stockholm, Sweden.; Department of Pathology, Västmanland Hospital Västerås, Västerås, Sweden., Stålhammar G; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Eugeniavägen 12, 17164, Stockholm, Sweden. gustav.stalhammar@ki.se.; Ocular Oncology Service, St. Erik Eye Hospital, Stockholm, Sweden. gustav.stalhammar@ki.se.; St. Erik Ophthalmic Pathology Laboratory, St. Erik Eye Hospital, Stockholm, Sweden. gustav.stalhammar@ki.se.

المصدر: Scientific reports [Sci Rep] 2024 Sep 24; Vol. 14 (1), pp. 22016. Date of Electronic Publication: 2024 Sep 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Uveal Neoplasms*/radiotherapy , Uveal Neoplasms*/epidemiology , Melanoma*/radiotherapy , Melanoma*/epidemiology , Brachytherapy*/adverse effects , Cataract Extraction* , Cataract*/epidemiology , Cataract*/etiology, Humans ; Female ; Male ; Middle Aged ; Aged ; Sex Factors ; Risk Factors ; Adult ; Incidence ; Sweden/epidemiology ; Aged, 80 and over

SCR Disease Name: Uveal melanoma

المؤلفون: Karlsson JW; Harry Perkins Institute of Medical Research and University of Western Australia, Perth, Australia.; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Sah VR; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Olofsson Bagge R; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden., Kuznetsova I; Harry Perkins Institute of Medical Research and University of Western Australia, Perth, Australia., Iqba M; Genomics WA, Telethon Kids Institute, Harry Perkins Institute of Medical Research and University of Western Australia, Nedlands, Australia., Alsen S; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Stenqvist S; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Saxena A; Genomics WA, Telethon Kids Institute, Harry Perkins Institute of Medical Research and University of Western Australia, Nedlands, Australia., Ny L; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Nilsson LM; Harry Perkins Institute of Medical Research and University of Western Australia, Perth, Australia.; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Nilsson JA; Harry Perkins Institute of Medical Research and University of Western Australia, Perth, Australia.; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

المصدر: ELife [Elife] 2024 Sep 23; Vol. 12. Date of Electronic Publication: 2024 Sep 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

مواضيع طبية MeSH: Uveal Neoplasms*/immunology , Uveal Neoplasms*/pathology , Uveal Neoplasms*/genetics , Melanoma*/immunology , Melanoma*/pathology , Melanoma*/secondary , Melanoma*/genetics , Lymphocytes, Tumor-Infiltrating*/immunology , Single-Cell Analysis*, Humans ; Animals ; Mice ; Liver Neoplasms/secondary ; Liver Neoplasms/immunology ; Liver Neoplasms/genetics ; Female ; Male ; Heterografts

SCR Disease Name: Uveal melanoma

المؤلفون: Jinhai Y; School of Optometry, Jiangxi Medical College, Nanchang University, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Research Institute of Ophthalmology and Visual Science, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Provincial Key Laboratory for Ophthalmology, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; National Clinical Research Center for Ocular Diseases Jiangxi Province Division, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China., Yunxiu C; School of Optometry, Jiangxi Medical College, Nanchang University, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Research Institute of Ophthalmology and Visual Science, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Provincial Key Laboratory for Ophthalmology, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; National Clinical Research Center for Ocular Diseases Jiangxi Province Division, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China., Qi J; National Clinical Research Center for Ocular Diseases Jiangxi Province Division, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Clinical Research Center for Ophthalmic Disease, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China., Jiancheng G; School of Optometry, Jiangxi Medical College, Nanchang University, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Research Institute of Ophthalmology and Visual Science, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Provincial Key Laboratory for Ophthalmology, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; National Clinical Research Center for Ocular Diseases Jiangxi Province Division, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China., Zhida P; National Clinical Research Center for Ocular Diseases Jiangxi Province Division, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China.; Jiangxi Clinical Research Center for Ophthalmic Disease, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China., Sha W; Department of Ophthalmology, Yuelu District, Third Xiangya Hospital, Tongzipo Road, ChangshaChangsha City, 410000, Jiangxi Province, China. wushawss@163.com., Hongfei L; National Clinical Research Center for Ocular Diseases Jiangxi Province Division, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China. feifei671919@163.com.; The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China. feifei671919@163.com.; Jiangxi Clinical Research Center for Ophthalmic Disease, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China. feifei671919@163.com., Qihua X; National Clinical Research Center for Ocular Diseases Jiangxi Province Division, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China. eye281016@163.com.; The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China. eye281016@163.com.; Jiangxi Clinical Research Center for Ophthalmic Disease, Bayi Avenue, Nanchang City, 330006, Jiangxi Province, China. eye281016@163.com.

المصدر: International ophthalmology [Int Ophthalmol] 2024 Sep 22; Vol. 44 (1), pp. 385. Date of Electronic Publication: 2024 Sep 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Country of Publication: Netherlands NLM ID: 7904294 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2630 (Electronic) Linking ISSN: 01655701 NLM ISO Abbreviation: Int Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Luteolin*/pharmacology , Uveal Neoplasms*/drug therapy , Uveal Neoplasms*/pathology , Spheroids, Cellular* , Melanoma*/drug therapy , Melanoma*/pathology , Cell Survival*/drug effects, Humans ; Tumor Cells, Cultured ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Culture Techniques, Three Dimensional/methods

SCR Disease Name: Uveal melanoma

المؤلفون: Lin N; Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; The First Clinical College, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Lv R; Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; The First Clinical College, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Yang D; Department of General Education Courses, Cangzhou Medical College, Hebei, China., Liu W; Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

المصدر: Medicine [Medicine (Baltimore)] 2024 Sep 06; Vol. 103 (36), pp. e39385.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Uveal Neoplasms*/genetics , Uveal Neoplasms*/mortality , Uveal Neoplasms*/immunology , Melanoma*/genetics , Melanoma*/mortality , Melanoma*/immunology , RNA, Long Noncoding*/genetics, Humans ; Prognosis ; Male ; Female ; Risk Assessment/methods ; Biomarkers, Tumor/genetics ; Middle Aged ; Proportional Hazards Models

SCR Disease Name: Uveal melanoma

المؤلفون: Klaassen L; Leiden University Medical Center, Department of Ophthalmology, Leiden, The Netherlands.; Leiden University Medical Center, Department of Radiology, Leiden, The Netherlands.; Leiden University Medical Center, Department of Radiation Oncology, Leiden, The Netherlands., Jaarsma-Coes MG; Leiden University Medical Center, Department of Ophthalmology, Leiden, The Netherlands.; Leiden University Medical Center, Department of Radiology, Leiden, The Netherlands., Marinkovic M; Leiden University Medical Center, Department of Ophthalmology, Leiden, The Netherlands., Luyten GPM; Leiden University Medical Center, Department of Ophthalmology, Leiden, The Netherlands., Rasch CRN; Leiden University Medical Center, Department of Radiation Oncology, Leiden, The Netherlands.; HollandPTC, Delft, The Netherlands., Ferreira TA; Leiden University Medical Center, Department of Radiology, Leiden, The Netherlands., Beenakker JM; Leiden University Medical Center, Department of Ophthalmology, Leiden, The Netherlands.; Leiden University Medical Center, Department of Radiology, Leiden, The Netherlands.; Leiden University Medical Center, Department of Radiation Oncology, Leiden, The Netherlands.

المصدر: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2024 Sep 03; Vol. 65 (11), pp. 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited Medium: Internet ISSN: 1552-5783 (Electronic) Linking ISSN: 01460404 NLM ISO Abbreviation: Invest Ophthalmol Vis Sci Subsets: MEDLINE

مواضيع طبية MeSH: Uveal Neoplasms*/radiotherapy , Uveal Neoplasms*/diagnostic imaging , Melanoma*/diagnostic imaging , Melanoma*/radiotherapy, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Magnetic Resonance Angiography/methods ; Magnetic Resonance Imaging/methods

SCR Disease Name: Uveal melanoma

المؤلفون: Gao YU; Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.; Department of Medicine, Clinic III, Hematology, Oncology and Palliative Medicine, University Medical Center Rostock, Rostock, Germany., Wendt S; Department of Medicine, Clinic III, Hematology, Oncology and Palliative Medicine, University Medical Center Rostock, Rostock, Germany., Krohn S; Department of Medicine, Clinic III, Hematology, Oncology and Palliative Medicine, University Medical Center Rostock, Rostock, Germany., Alammar M; Department of Medicine, Clinic III, Hematology, Oncology and Palliative Medicine, University Medical Center Rostock, Rostock, Germany., Junghanss C; Department of Medicine, Clinic III, Hematology, Oncology and Palliative Medicine, University Medical Center Rostock, Rostock, Germany., Nolte I; Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Escobar HM; Department of Medicine, Clinic III, Hematology, Oncology and Palliative Medicine, University Medical Center Rostock, Rostock, Germany hugo.murua.escobar@med.uni-rostock.de.

المصدر: Anticancer research [Anticancer Res] 2024 Sep; Vol. 44 (9), pp. 3843-3848.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Uveal Neoplasms*/drug therapy , Uveal Neoplasms*/pathology , Uveal Neoplasms*/genetics , Melanoma*/drug therapy , Melanoma*/pathology , Melanoma*/genetics , Melanoma*/metabolism , Cell Proliferation*/drug effects , Apoptosis*/drug effects, Humans ; Cell Line, Tumor ; Protein Kinase Inhibitors/pharmacology ; Mutation ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Cell Survival/drug effects ; Antineoplastic Agents/pharmacology ; Phenylurea Compounds/pharmacology ; Pyrimidines

SCR Disease Name: Uveal melanoma

المؤلفون: Turcios Escobar S; Department of Pathology, University of Illinois Hospital & Health Sciences System, Chicago, Illinois, USA., Yang R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Journal of cutaneous pathology [J Cutan Pathol] 2024 Sep; Vol. 51 (9), pp. 644-648. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0425124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0560 (Electronic) Linking ISSN: 03036987 NLM ISO Abbreviation: J Cutan Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/genetics , Melanoma*/diagnosis , Melanoma*/pathology , Melanoma*/secondary , Skin Neoplasms*/genetics , Skin Neoplasms*/pathology , Skin Neoplasms*/secondary , Skin Neoplasms*/diagnosis , Skin Neoplasms*/metabolism , Ubiquitin Thiolesterase*/genetics , Ubiquitin Thiolesterase*/metabolism , High-Throughput Nucleotide Sequencing*/methods , Uveal Neoplasms*/genetics , Uveal Neoplasms*/pathology , Uveal Neoplasms*/diagnosis , Uveal Neoplasms*/secondary , Uveal Neoplasms*/metabolism, Humans ; Male ; Aged ; Tumor Suppressor Proteins/genetics ; Mutation ; GTP-Binding Protein alpha Subunits/genetics ; Nivolumab/therapeutic use ; Neoplasms, Unknown Primary/pathology ; Neoplasms, Unknown Primary/genetics ; Neoplasms, Unknown Primary/diagnosis

SCR Disease Name: Uveal melanoma

المؤلفون: Alsoudi AF; Department of Ophthalmology, Baylor College of Medicine, Houston, Texas., Skrehot HC; School of Medicine, Baylor College of Medicine, Houston, Texas., Chévez-Barrios P; Department of Ophthalmology, Baylor College of Medicine, Houston, Texas.; Department of Pathology and Genomic Medicine, Weill Cornell Medicine, Houston Methodist Hospital, Houston, Texas.; Blanton Eye Institute, Weill Cornell Medicine, Houston Methodist Hospital, Houston, Texas; and., Divatia M; Department of Pathology and Genomic Medicine, Weill Cornell Medicine, Houston Methodist Hospital, Houston, Texas., De La Garza M; Department of Pathology and Genomic Medicine, Weill Cornell Medicine, Houston Methodist Hospital, Houston, Texas., Bretana ME; Retina Consultants of Texas, Houston, Texas., Schefler AC; Blanton Eye Institute, Weill Cornell Medicine, Houston Methodist Hospital, Houston, Texas; and.; Retina Consultants of Texas, Houston, Texas.

المصدر: Retina (Philadelphia, Pa.) [Retina] 2024 Sep 01; Vol. 44 (9), pp. 1580-1589.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Uveal Neoplasms*/genetics , Uveal Neoplasms*/diagnosis , Melanoma*/genetics , High-Throughput Nucleotide Sequencing* , Antigens, Neoplasm*/genetics , Gene Expression Profiling*/methods , Biomarkers, Tumor*/genetics, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Mutation ; Adult ; Gene Expression Regulation, Neoplastic ; Aged, 80 and over ; Eukaryotic Initiation Factor-1/genetics ; RNA Splicing Factors/genetics ; RNA Splicing Factors/metabolism ; Brachytherapy ; Phosphoproteins ; Tumor Suppressor Proteins ; Ubiquitin Thiolesterase

SCR Disease Name: Uveal melanoma

المؤلفون: Hussain RN; Liverpool Ocular Oncology Centre, Liverpool University Hospitals Foundation Trust, Liverpool, UK. Electronic address: rumanahussain@hotmail.com., Coupland SE; Liverpool Clinical Laboratories, Liverpool University Hospitals Foundation Trust, Liverpool, UK., Heimann H; Liverpool Ocular Oncology Centre, Liverpool University Hospitals Foundation Trust, Liverpool, UK., Eleuteri A; NHS Digital Services, Liverpool University Hospitals NHS Foundation Trust, Kilby House, Liverpool Innovation Park, Liverpool, UK.

المصدر: Ophthalmology [Ophthalmology] 2024 Sep; Vol. 131 (9), pp. e39. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnosis , Uveal Neoplasms*/diagnosis , Uveal Neoplasms*/mortality, Humans ; Time-to-Treatment ; Delayed Diagnosis

SCR Disease Name: Uveal melanoma

المؤلفون: Koch EAT; Department of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), CCC Erlangen-EMN, 91054, Erlangen, Germany., Heppt MV; Department of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), CCC Erlangen-EMN, 91054, Erlangen, Germany., Berking C; Department of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), CCC Erlangen-EMN, 91054, Erlangen, Germany. Carola.Berking@uk-erlangen.de.

المصدر: American journal of clinical dermatology [Am J Clin Dermatol] 2024 Sep; Vol. 25 (5), pp. 691-700. Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/pathology , Melanoma*/secondary , Uveal Neoplasms*/drug therapy , Uveal Neoplasms*/pathology, Humans ; Molecular Targeted Therapy ; Liver Neoplasms/secondary ; Liver Neoplasms/drug therapy ; Immune Checkpoint Inhibitors/therapeutic use ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Randomized Controlled Trials as Topic

SCR Disease Name: Uveal melanoma